Top Stories
Eleusis Benefit Corp: Taking the “Psychedelic” Out of Psychedelics Shlomi Raz, CEO of Eleusis Benefit Corporation, made false claims about psychedelics. We asked multiple ethnobotanists, a medical anthropologist, and a chemist if they could help us set the record straight.
Using psychedelic compounds to treat inflammation is interesting, but claiming that, "the primary traditional use," of psychedelics was, "as imperceptible anti-inflammatory agents," just isn’t true.
Chicago could become largest city to Decriminalize Entheogenic Plants
Become a member
and support our work.
Lucy In the Sky with Nazis
We discuss our recent article, Lucy in the Sky with Nazis: Psychedelics and the Right Wing, which stirred up quite a bit of controversy. So to stir things up a little more, we’ve unpacked some of our perspectives while exploring questions of psychedelics as non-specific amplifiers of consciousness, the far right, the so-called “Intellectual Dark Web,” white supremacy, and psychedelics and social change.
Join Our Newsletter
Independent drug journalism. In your inbox.
Psychedelic Sisters in Arms
A series of personal stories on consent, gender, and sexual violence against women in psychedelic communities.
Popular Reads
BBC Duped into Promoting Marketing Scheme for Microdosing Psychedelics A recent BBC story entitled “The ‘psychedelics coach’ with drug-fuelled career advice,” offers an opportunity to examine what happens when sloppy journalism and self-promotional psychedelic marketers collide.
A recent BBC story entitled “The ‘psychedelics coach’ with drug-fuelled career advice,” offers an opportunity to examine what happens when sloppy journalism and self-promotional psychedelic marketers collide.
Join Our
Newsletter
Independent drug journalism. In your inbox.
PSYCHEDELIC SISTERS IN ARMS
A series of personal stories on consent, gender, and sexual violence against women in psychedelic communities.
